The study was conducted by the Global Vaccine Data Network on more than 99 million people. Eight countries were the focus of this project (Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland), and the results were published in the journal Vaccine.
© iStock
Researchers’ words (8/10)
“Most of those vaccinated were between 20 and 59 years old, and the largest number of doses were administered in France,” explained the researchers, specifying that the vaccines came from Pfizer, Moderna, and AstraZeneca. The results obtained did not reassure healthcare professionals, and even less so patients.
© iStock
Guillain-Barré syndrome and venous thrombosis (9/10)
The researchers noted an increase in the number of cases of Guillain-Barré syndrome and cerebral venous thrombosis after the first dose of the AstraZeneca vaccine. Guillain-Barré syndrome is primarily characterized by muscle weakness, while venous thrombosis is the formation of a blood clot in a vein, preventing proper blood flow throughout the body. French NBA star Victor Wembanyama suffered from the latter condition a few months ago, forcing his season to end.
© iStock
Further research is needed (10/10)
Continued on the next page
Furthermore, all vaccines significantly increased the risk of myocarditis and pericarditis (inflammation affecting the myocardium, the muscle responsible for heart contraction and blood circulation in the body). “Other warning signs requiring further investigation have been identified,” the journal states. The researchers emphasize that further research is needed to determine the link between the vaccine and these side effects.
© iStock
Given an alarming situation, Covid-19 vaccines were developed in a rush. After nearly five years of hindsight and analysis, we now know the adverse effects of the various serums we have been injected with.
Thank you to everyone who reads this.
ADVERTISEMENT
